Biorestorative Therapies Inc. (BRTX)
BioRestorative Therapies, Inc. (BRTX) Q2 2024 Earnings Call Transcript
Start Time: 16:30 January 1, 0000 5:03 PM ET BioRestorative Therapies, Inc. (NASDAQ:BRTX ) Q2 2024 Earnings Conference Call August 13, 2024, 16:30 PM ET Company Participants Lance Alstodt - President, CEO and Chairman Robert Kristal - CFO Francisco Silva - VP, R&D Stephen Kilmer - Head of IR Conference Call Participants Jonathan Aschoff - ROTH MKM Michael Okunewitch - The Maxim Group Elemer Piros - Rodman and Renshaw Operator Good afternoon, and welcome to the BioRestorative Therapies Second Quarter 2024 Investor Call. At this time, all participants are in a listen-only mode and we will open for questions following the presentation.
Biorestorative Therapies, Inc. (BRTX) Reports Q2 Loss, Tops Revenue Estimates
Biorestorative Therapies, Inc. (BRTX) came out with a quarterly loss of $0.50 per share versus the Zacks Consensus Estimate of a loss of $0.56. This compares to loss of $0.77 per share a year ago.
Why Is BioRestorative Therapeutics (BRTX) Stock Up 42% Today?
BioRestorative Therapeutics (NASDAQ: BRTX ) stock is taking off on Thursday following news that the medical company is in negotiations with an undisclosed commercial-stage regenerative medicine company. These negotiations cover a potential license for BioRestorative Therapeutics' ThermoStem metabolic intellectual property.
Biorestorative Therapies, Inc. (BRTX) Reports Q1 Loss, Tops Revenue Estimates
Biorestorative Therapies, Inc. (BRTX) came out with a quarterly loss of $0.53 per share versus the Zacks Consensus Estimate of a loss of $0.51. This compares to loss of $1.53 per share a year ago.
